Recombinant Peptides

Recombinant Peptides

Theertha dedicated to expanding access to vital diabetes care. Our portfolio includes a range of biosimilar peptide products designed for the treatment of both type 1 and type 2 diabetes. Recognizing the importance of affordability and quality in healthcare, we actively collaborate with partners to bring these essential therapies to market or offer technology transfer to clients. Join us in our mission to support the diabetes community with reliable solutions, and together, we'll make a meaningful difference in the lives of those who need it most.